Quick answer
Rezum, UroLift, iTind, Aquablation and transperineal laser ablation (EchoLaser) are treatments for an enlarged prostate that preserved ejaculation in most of the men studied.1,2 The studies that placed Rezum alongside them found similar improvement to UroLift, faster improvement with transperineal laser ablation and somewhat greater improvement with Aquablation.6,7,9 Repeat surgery at 5 years ranged from 11% to 16% with Rezum and UroLift, and was below 6% with Aquablation.3,4 I assess all of them with each patient, together with the traditional operations.
How each one works
- Rezum: a fine needle releases water vapor inside the prostate, and the body absorbs the treated tissue over the following weeks.1
- UroLift: small implants hold the prostate lobes to the sides, without removing tissue. They stay in the body.1
- iTind: a nitinol device stays in the urethra for 5 to 7 days, opens the channel by pressure and is then removed.1
- Aquablation: a water jet, guided by ultrasound, removes the tissue without heat.1
- EchoLaser: fine needles go in through the perineum, guided by ultrasound, and carry laser fibers into the prostate, without passing through the urethra.1
The other treatments are animated on the pages Urolift, iTind, Optilume and Aquablation and EchoLaser.
Ejaculation and repeat surgery with each treatment
| Treatment | Loss of ejaculation | Repeat surgery |
|---|---|---|
| Rezum | 3% | 11.1% at 5 years |
| UroLift | 0% | 13.6% at 5 years |
| iTind | 1% | 11.1% at 4 years |
| Optilume | 0% | 2.5% at 2 years |
| EchoLaser | 5% | Follow-up still short |
| Aquablation | 10% | 4.4% to 6% at 5 years |
Loss of ejaculation comes from a review of 24 studies2 and, for Aquablation, from the WATER trial cited by the European guideline.1 Repeat surgery comes from a review of 99 studies.3 The numbers come from different studies and time frames, not from a direct comparison. In that review, 65% of the studies had a high risk of manufacturer influence, and the authors advise caution with the results.3
In a United States database with more than 420,000 procedures, repeat surgery at 5 years was 16% with UroLift and 14% with Rezum, compared with 7.1% with TURP and 4.4% with laser enucleation.4
Rezum or UroLift
In a study from Singapore, 86 men had Rezum and 62 had UroLift, with 2 years of follow-up. Symptoms, quality of life and flow improved similarly. With Rezum, the catheter stayed longer and mild complications were more common (41.9% versus 16.1%), mainly blood in the urine and urinary infection. Serious complications did not differ. Repeat surgery was 8.1% with UroLift and did not occur with Rezum.6
In a United States database with 3,697 men, reintervention at 3 years was similar with the two treatments. In men aged 65 or older, it was lower with Rezum.5
The European guideline recommends UroLift for prostates under 70 g without a median lobe. With Rezum, the median lobe can receive 1 to 2 vapor treatments.1 In practice, this has to be assessed case by case.
Rezum or transperineal laser ablation (EchoLaser)
The first randomized trial between the two treatments assigned 80 men. Both procedures were done under sedation, and all but one went home the same day. At 3 and 6 months, symptoms and quality of life improved more, and faster, with transperineal laser ablation. Flow and residual urine improved similarly.7 In the same trial, erections were preserved in both groups and the ejaculation score improved.8 Follow-up is still only 6 months.
In my practice, Rezum and EchoLaser are done under local anesthesia with sedation. Rezum is done without a hospital stay, and EchoLaser with a short hospital admission: you arrive and go home the same day. The catheter stays for 5 to 7 days with Rezum and 7 days with EchoLaser. The full comparison of the two techniques is in EchoLaser or Rezum.
Rezum or Aquablation
In a study from Israel, with prostates under 80 g, 324 men had Aquablation and 104 had Rezum. Symptom improvement was somewhat greater with Aquablation, and urgency settled faster. Rezum had a shorter procedure and same-day discharge. Erections and ejaculation were preserved in most men in both groups, and complications and repeat surgery were low and similar.9 Patients chose their own treatment and the groups differed at the start, so the study does not show which is better.
The European guideline recommends Aquablation for prostates of 30 to 80 g and still classes Rezum as a technique under evaluation.1 In practice, this has to be assessed case by case.
Rezum or iTind
I did not find a study comparing the two directly. In one review, loss of ejaculation was 3% with Rezum and 1% with iTind.2 In another, repeat surgery was 11.1% with both, at 5 years with Rezum and at 4 years with iTind.3 The European guideline classes both as techniques under evaluation.1
How I approach it
I was one of the pioneers of Rezum in Brazil, performing some of the first procedures in the country in July 2023, and I am one of the urologists with the highest number of Rezum procedures in Brazil, with more than 100 cases among my own patients and proctoring. As a proctor, I guide urologists from many parts of São Paulo and Brazil through their first cases.
All of these treatments are options I assess with each patient, together with TURP, Greenlight and HoLEP. Before recommending one, I look at the size and shape of the prostate, whether there is a median lobe, your symptoms, your medications and what you want to preserve. We make the decision together. The comparison with traditional surgery is in Rezum or TURP. The first consultation can be online, in English.
When to see a urologist
- If you have an enlarged prostate and medications do not bring enough relief
- If preserving ejaculation matters to your decision
- If you want to compare Rezum with another minimally invasive treatment
- If you have had one of these treatments and your symptoms have come back
Send your case
If you would like to know, before a consultation, which technique makes sense for your case, fill in the form below. If you know it, tell me the prostate weight on ultrasound or MRI and the medications you take. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.
Frequently asked questions
Rezum or UroLift: which is better?+
In a study from Singapore, with 2 years of follow-up, symptom and flow improvement was similar. With Rezum, the catheter stayed longer and there were more mild complications, such as blood in the urine and infection; with UroLift, repeat surgery was more frequent (8.1% versus none).6 In a United States database, reintervention at 3 years was similar, and lower with Rezum in men aged 65 or older.5
Rezum or transperineal laser ablation (EchoLaser): which is better?+
In the first randomized trial between the two, with 80 men, symptoms and quality of life improved more, and faster, with transperineal laser ablation at 3 and 6 months, and flow improved similarly.7 Erections were preserved with both.8 In my practice, both are done under local anesthesia with sedation. Rezum is done without a hospital stay, and EchoLaser with a short hospital admission: you arrive and go home the same day. The catheter stays for 5 to 7 days with Rezum and 7 days with EchoLaser.
Rezum or Aquablation: which is better?+
In a study from Israel, with prostates under 80 g, symptom improvement was somewhat greater with Aquablation, and Rezum had a shorter procedure and same-day discharge. Sexual function was preserved with both, and complications and repeat surgery were low and similar.9 That study was not randomized.
Rezum or iTind: which is better?+
I did not find a study comparing the two directly. In one review, loss of ejaculation was 3% with Rezum and 1% with iTind.2 In another, repeat surgery was 11.1% with both, at 5 years with Rezum and at 4 years with iTind.3
Which of these treatments preserves ejaculation best?+
All of them preserve it in most men. In a review of 24 studies, loss of ejaculation was 5% with transperineal laser ablation, 3% with Rezum, 1% with iTind and none with UroLift and Optilume.2 With Aquablation, it was 10% in the WATER trial.1
After which one is repeat surgery more common?+
In a review of 99 studies, repeat surgery at 5 years was 13.6% with UroLift, 11.1% with Rezum and 4.4% to 6% with Aquablation.3 In a United States database, at 5 years, it was 16% with UroLift and 14% with Rezum, compared with 7.1% with TURP.4
I have a median lobe. Does that change the choice?+
It can. The European guideline recommends UroLift for prostates without a median lobe. With Rezum, the median lobe can receive 1 to 2 vapor treatments.1 In practice, this has to be assessed case by case.
Can I have any of these treatments?+
That depends on the size and shape of your prostate, your symptoms and what you want to preserve. I assess all of them with you, together with the traditional operations.
Who can help me choose between Rezum and the other treatments in Brazil?+
I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I was one of the pioneers of Rezum in Brazil, performing some of the first procedures in the country in July 2023, and I am one of the urologists with the highest number of Rezum procedures in Brazil, with more than 100 cases among my own patients and proctoring. I also proctor colleagues from São Paulo and other states. My office is in Vila Mariana, and the first consultation can be in person or online, in English.
References
- EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology; 2026. Treatment chapter. EAU
- Franco A, Ditonno F, Manfredi C, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. 2026;89(4):318-331. PubMed
- Akgul B, Tozsin A, Aydın A, et al. Reintervention rates after minimally invasive benign prostatic hyperplasia therapies: a systematic review including industry involvement. World J Urol. 2025;43(1):494. PubMed
- Carletti F, Tamborino F, Turcan A, et al. Five-year Retreatment and Medication Restart Rates Following Benign Prostate Hyperplasia Treatments: A Nationwide Real-world Analysis Using Epic Cosmos. Eur Urol Focus. 2026;12(3):383-392. PubMed
- Lu YC, Chiu AW, Ho CH, et al. Comparative Analysis of 3-Year Reintervention Rates for Rezum vs. UroLift: A TriNetX Study. Int J Urol. 2026;33(7):e70550. PubMed
- Law YXT, Chen WJK, Shen L, et al. Convective Water Vapor Energy Ablation (Rezum) Versus Prostatic Urethral Lift (Urolift): A 2-Year Prospective Study. J Endourol. 2024;38(12):1387-1394. PubMed
- Pacini M, Zucchi A, Salonia A, et al. Short term results after minimally invasive treatments for benign prostatic enlargement: the first randomized trial comparing transperineal laser ablation and water vapor ablation. Prostate Cancer Prostatic Dis. 2025;28(4):978-984. PubMed
- Zucchi A, Bartoletti R, Antonov P, et al. Preserving erectile and ejaculatory function in patients undergoing minimally invasive techniques: the first randomized clinical trial comparing convective water vapor ablation and transperineal laser ablation. J Sex Med. 2025;22(8):1447-1454. PubMed
- Perez D, Mamber A, Pasherstnik M, et al. Image-Guided Robotic-Assisted Waterjet Ablation of Prostate (Aquablation) Versus Convective Water Vapor Thermal Therapy (Rezūm) in Patients with Prostate Volume Less than 80 Grams. J Laparoendosc Adv Surg Tech A. 2026;36(6):417-422. PubMed
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation5.0186 Google reviews
